Viewing Study NCT04555304


Ignite Creation Date: 2025-12-24 @ 8:01 PM
Ignite Modification Date: 2025-12-28 @ 2:11 PM
Study NCT ID: NCT04555304
Status: UNKNOWN
Last Update Posted: 2020-09-18
First Post: 2020-08-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy
Sponsor: Chengdu Kanghong Biotech Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module